Cochrane Abstracts
Tamoxifen and aromatase inhibitors for relapse of tubo‐ovarian high‐grade serous cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tamoxifen and Aromatase Inhibitors for Relapse of Tubo‐ovarian high‐grade Serous Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435659/all/Tamoxifen_and_aromatase_inhibitors_for_relapse_of_tubo‐ovarian high‐grade_serous_cancer. Accessed 14 September 2024.
Tamoxifen and aromatase inhibitors for relapse of tubo‐ovarian high‐grade serous cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435659/all/Tamoxifen_and_aromatase_inhibitors_for_relapse_of_tubo‐ovarian high‐grade_serous_cancer. Accessed September 14, 2024.
Tamoxifen and aromatase inhibitors for relapse of tubo‐ovarian high‐grade serous cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435659/all/Tamoxifen_and_aromatase_inhibitors_for_relapse_of_tubo‐ovarian high‐grade_serous_cancer
Tamoxifen and Aromatase Inhibitors for Relapse of Tubo‐ovarian high‐grade Serous Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 September 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435659/all/Tamoxifen_and_aromatase_inhibitors_for_relapse_of_tubo‐ovarian high‐grade_serous_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tamoxifen and aromatase inhibitors for relapse of tubo‐ovarian high‐grade serous cancer
ID - 435659
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435659/all/Tamoxifen_and_aromatase_inhibitors_for_relapse_of_tubo‐ovarian high‐grade_serous_cancer
DB - Evidence Central
DP - Unbound Medicine
ER -
